List of bibliographic references
Number of relevant bibliographic references: 24.
[0-20] [
0 - 20][
0 - 24][
20-23][
20-40]
Ident. | Authors (with country if any) | Title |
---|
000212 (2000) |
H H Fernandez [États-Unis] ; J H Friedman ; J. Grace ; S. Beason-Hazen | Donepezil for Huntington's disease. |
000836 (2002) |
Andrew Siderowf [États-Unis] ; Michael Mcdermott ; Karl Kieburtz ; Karen Blindauer ; Sandra Plumb ; Ira Shoulson | Test-retest reliability of the unified Parkinson's disease rating scale in patients with early Parkinson's disease: results from a multicenter clinical trial. |
000B15 (2003) |
Juha-Matti Savola [Finlande] ; Michael Hill ; Mia Engstrom ; Hannele Merivuori ; Siegfried Wurster ; Steven G. Mcguire ; Susan H. Fox ; Alan R. Crossman ; Jonathan M. Brotchie | Fipamezole (JP-1730) is a potent alpha2 adrenergic receptor antagonist that reduces levodopa-induced dyskinesia in the MPTP-lesioned primate model of Parkinson's disease. |
000E96 (2004) |
Matthew B. Stern [États-Unis] ; Kenneth L. Marek ; Joseph Friedman ; Robert A. Hauser ; Peter A. Lewitt ; Daniel Tarsy ; C Warren Olanow | Double-blind, randomized, controlled trial of rasagiline as monotherapy in early Parkinson's disease patients. |
001217 (2005) |
Christopher G. Goetz [États-Unis] ; Werner Poewe [Autriche] ; Olivier Rascol ; Cristina Sampaio | Evidence-based medical review update: pharmacological and surgical treatments of Parkinson's disease: 2001 to 2004. |
001224 (2005) |
C Warren Olanow [États-Unis] ; Joseph Jankovic [États-Unis] | Neuroprotective therapy in Parkinson's disease and motor complications: a search for a pathogenesis-targeted, disease-modifying strategy. |
001381 (2005) |
Anthony E. Lang [Canada] | Treatment of progressive supranuclear palsy and corticobasal degeneration. |
001496 (2006) |
Marc J. Mentis [États-Unis] ; Dominique Delalot [États-Unis] ; Hassan Naqvi [États-Unis] ; Mark F. Gordon [États-Unis] ; Mark Gudesblatt [États-Unis] ; Christine Edwards [États-Unis] ; Luke Donatelli [États-Unis] ; Vijay Dhawan [États-Unis] ; David Eidelberg [États-Unis] | Anticholinesterase Effect on Motor Kinematic Measures and Brain Activation in Parkinson’s Disease |
001556 (2006) |
Kevin M. Biglan [États-Unis] ; Steven Schwid ; Shirley Eberly ; Karen Blindauer ; Stanley Fahn ; Tamar Goren ; Karl Kieburtz ; David Oakes ; Sandra Plumb ; Andrew Siderowf ; Matthew Stern ; Ira Shoulson | Rasagiline improves quality of life in patients with early Parkinson's disease. |
001849 (2006) |
Helmut Niederhofer | Donepezil also effective in the treatment of Tourette's syndrome? |
001F07 (2008) |
Sonia Brucki ; Ricardo Nitrini | Camptocormia in Alzheimer's disease: an association? |
001F54 (2008) |
Francisco Coria [Espagne] ; María Del Puig Cozar-Santiago | Rasagiline improves freezing in a patient with primary progressive freezing gait. |
002380 (2008) |
C Warren Olanow [États-Unis] ; Robert A. Hauser ; Joseph Jankovic [États-Unis] ; William Langston ; Anthony Lang ; Werner Poewe [Autriche] ; Eduardo Tolosa ; Fabrizio Stocchi ; Eldad Melamed ; Eli Eyal ; Olivier Rascol | A randomized, double-blind, placebo-controlled, delayed start study to assess rasagiline as a disease modifying therapy in Parkinson's disease (the ADAGIO study): rationale, design, and baseline characteristics. |
002431 (2010) |
Stuart H. Isaacson | Selective MAO-B inhibitors have low potential for the tyramine effect. |
002486 (2009) |
Nir Giladi [Israël] ; Joseph Tal ; Tali Azulay ; Oliver Rascol ; David J. Brooks ; Eldad Melamed ; Wolfgang Oertel ; Werner Poewe [Autriche] ; Fabrizio Stocchi ; Eduardo Tolosa | Validation of the freezing of gait questionnaire in patients with Parkinson's disease. |
002807 (2009) |
Rosalind S. Chuang ; Anthony E. Lang | Rasagiline-induced spontaneous ejaculation. |
002E52 (2010) |
Tom H. Johnston [Canada] ; Susan H. Fox ; Matthew J. Piggott ; Juha-Matti Savola ; Jonathan M. Brotchie | The α₂ adrenergic antagonist fipamezole improves quality of levodopa action in Parkinsonian primates. |
003061 (2011) |
Robert A. Hauser [États-Unis] ; Peggy Auinger | Determination of minimal clinically important change in early and advanced Parkinson's disease. |
003149 (2011) |
Hasmet A. Hanagasi [Turquie] ; Hakan Gurvit ; P Nar Unsalan ; Hilal Horozoglu ; Nese Tuncer ; Aynur Feyzioglu ; Dilek Ince Gunal ; Gorsev G. Yener ; Raif Cakmur ; Huseyin A. Sahin ; Murat Emre | The effects of rasagiline on cognitive deficits in Parkinson's disease patients without dementia: a randomized, double-blind, placebo-controlled, multicenter study. |
003403 (2011) |
Peter Jenner [Royaume-Uni] ; J William Langston | Explaining ADAGIO: a critical review of the biological basis for the clinical effects of rasagiline. |
003774 (2012) |
Bruno Dubois [France] ; Eduardo Tolosa ; Regina Katzenschlager ; Murat Emre ; Andrew J. Lees ; Günther Schumann ; Emmanuelle Pourcher ; Julian Gray ; Gail Thomas ; Jina Swartz ; Timothy Hsu ; Margaret L. Moline | Donepezil in Parkinson's disease dementia: a randomized, double-blind efficacy and safety study. |
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Ncbi/Curation
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i -k "Indans (therapeutic use)"
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i \
-Sk "Indans (therapeutic use)" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Santé
|area= MovDisordV3
|flux= Ncbi
|étape= Curation
|type= indexItem
|index= KwdEn.i
|clé= Indans (therapeutic use)
}}
| This area was generated with Dilib version V0.6.23. Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024 | |